Document is current
Any future updates will be listed below
-
Authors
Zhang, Peijin
De Oliveira, Claudia H. M. C.
Yu, Kyungha
Basdeo, Shenita
Charriez, Christina M.
Syto, Mary
Thomas, Mark
Murthy, Bindu
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05337345 at ClinicalTrials.govDocuments that mention this clinical trial
Pharmacokinetic Characterization of Cendakimab Administered with Different Devices and at Different Injection Sites in Healthy Participants
https://doi.org/10.1007/s13318-025-00949-0
-
Funding
Funding for this research was provided by:
Bristol Myers Squibb
- License Information
-
More Information
Article History
Accepted: 22 April 2025
First Online: 15 May 2025
Declarations
:
: This study was funded by Bristol Myers Squibb.
: All authors are employees of and own shares in Bristol Myers Squibb.
: This study was conducted in accordance with the trial protocol and with Good Clinical Practice guidelines developed by the International Council for Harmonisation and with ethics committee approval (approval number, MOD01504404; 28 November 2022). The study is registered at ClinicalTrials.gov (NCT05337345).
: All participants provided written informed consent before participating in the study.
: All participants provided consent for publication before participating in the study.
: Not applicable
: Bristol Myers Squibb will honor legitimate requests for clinical trial data from qualified researchers. Data will be shared with external researchers whose proposed use of the data has been approved. Complete de-identified patient data sets will be eligible for sharing 2 years after completion of the study. Before data are released the researcher(s) must sign a Data Sharing Agreement after which the de-identified and anonymized datasets can be accessed within a secured portal. Bristol Myers Squibb policy on data sharing may be found at . Further information is available from the corresponding author upon request.
: Conceptualization: P.Z., C.H.M.C.D.O., K.Y., C.M.C., M.S., M.T., B.M. Formal analysis: S.B. Supervision: P.Z. Writing—review and editing: P.Z., C.H.M.C.D.O., K.Y., S.B., C.M.C., M.S., M.T., B.M.
